Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0CQUES
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HS630
|
|||||
| Synonyms |
Recombinant anti-HER2 human monoclonal antibody-DM1(Zhejiang Hisun Pharmaceutical Co., Ltd.); HS 630; HS-630
Click to Show/Hide
|
|||||
| Organization |
Zhejiang Hisun Pharmaceutical Co., Ltd.; Beijing Mabworks Biotech Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Mertansine DM1
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.